Infectious Respiratory Disease Diagnostics Market Size, Share, Trends, Growth Outlook

Infectious Respiratory Disease Diagnostics Market is estimated to increase at a growth rate of 2.3% CAGR over the forecast period from 2024 to 2030.

 

The Infectious Respiratory Disease Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others).

 

An Introduction to Infectious Respiratory Disease Diagnostics Market in 2024

The infectious respiratory disease diagnostics market in 2024 addresses the urgent need for accurate and timely diagnosis of respiratory infections, including viral, bacterial, and fungal pathogens that affect the upper and lower respiratory tract. Respiratory infections pose significant public health challenges due to their high prevalence, potential for rapid transmission, and association with severe illness and mortality, particularly in vulnerable populations such as children, elderly individuals, and immunocompromised patients. Key diagnostic modalities include molecular assays, immunoassays, and point-of-care tests targeting respiratory pathogens such as influenza viruses, respiratory syncytial virus (RSV), and SARS-CoV-2. Market dynamics are driven by factors such as the increasing incidence of respiratory infections, seasonal outbreaks of influenza and other respiratory viruses, and the ongoing COVID-19 pandemic. Collaboration between diagnostic companies, public health agencies, and healthcare providers fuels innovation in respiratory disease diagnostics, leading to the development of multiplex panels, rapid antigen tests, and digital platforms that enhance surveillance, outbreak detection, and patient management strategies, thereby mitigating the impact of respiratory diseases on global health and economies.

Infectious Respiratory Disease Diagnostics Market Trend: Integration of Artificial Intelligence (AI) in Infectious Respiratory Disease Diagnostics

A notable trend in the Infectious Respiratory Disease Diagnostics market is the increasing integration of artificial intelligence (AI) technologies. AI-based algorithms are being developed and incorporated into diagnostic platforms to enhance the accuracy, speed, and efficiency of respiratory pathogen detection and identification. These AI-powered systems analyze complex datasets from various sources, including clinical samples, imaging studies, and patient medical records, to provide rapid and precise diagnoses of infectious respiratory diseases. By leveraging machine learning and deep learning algorithms, AI-enabled diagnostic solutions can improve sensitivity and specificity, optimize treatment decisions, and support infection control measures, thereby driving the adoption of advanced diagnostic technologies in respiratory disease management.

Infectious Respiratory Disease Diagnostics Market Driver: Rising Incidence of Respiratory Infections and Outbreaks

A significant driver in the Infectious Respiratory Disease Diagnostics market is the rising incidence of respiratory infections and outbreaks. Infectious respiratory diseases, including influenza, pneumonia, tuberculosis, and respiratory syncytial virus (RSV) infections, continue to pose substantial public health challenges globally, leading to significant morbidity, mortality, and economic burden. Factors such as population growth, urbanization, environmental pollution, antimicrobial resistance, and international travel contribute to the spread and resurgence of respiratory pathogens, exacerbating the burden of respiratory infections. As healthcare systems prioritize early detection, surveillance, and management of respiratory diseases, there is growing demand for accurate and timely diagnostic tools to facilitate prompt intervention, outbreak control, and preventive measures, thereby fueling market growth for respiratory disease diagnostics.

Infectious Respiratory Disease Diagnostics Market Opportunity: Development of Multiplex Molecular Diagnostic Panels

An opportunity for market growth in the Infectious Respiratory Disease Diagnostics market lies in the development of multiplex molecular diagnostic panels. Multiplex molecular diagnostic assays allow simultaneous detection and differentiation of multiple respiratory pathogens from a single clinical sample, offering advantages in terms of efficiency, cost-effectiveness, and comprehensive diagnostic coverage. By targeting a broad range of viral, bacterial, and fungal respiratory pathogens, multiplex panels enable rapid identification of the causative agents responsible for respiratory infections, facilitating timely treatment decisions and infection control measures. Furthermore, multiplex assays support syndromic testing approaches, which enhance diagnostic yield and streamline laboratory workflows, thereby addressing the increasing demand for multiparametric respiratory diagnostics in clinical and public health settings. Investing in the development and commercialization of multiplex molecular diagnostic panels presents an opportunity for diagnostic manufacturers to meet the evolving needs of healthcare providers and contribute to the advancement of respiratory disease diagnostics.

 

Infectious Respiratory Disease Diagnostics Market Segmentation

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

 

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

 

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

 

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

 

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Infectious Respiratory Disease Diagnostics Market Companies

Abbott

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories Inc

Danaher

F. Hoffmann-La Roche Ltd

Koninklijke Philips N.V.

Qiagen

Quidel Corp

Siemens Healthcare GmbH

Thermo Fisher Scientific Inc

*- List Not Exhaustive

 

Reasons to Buy the Infectious Respiratory Disease Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Infectious Respiratory Disease Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Infectious Respiratory Disease Diagnostics Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Infectious Respiratory Disease Diagnostics Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Infectious Respiratory Disease Diagnostics Market Size Outlook, $ Million, 2021 to 2030

3.2 Infectious Respiratory Disease Diagnostics Market Outlook by Type, $ Million, 2021 to 2030

3.3 Infectious Respiratory Disease Diagnostics Market Outlook by Product, $ Million, 2021 to 2030

3.4 Infectious Respiratory Disease Diagnostics Market Outlook by Application, $ Million, 2021 to 2030

3.5 Infectious Respiratory Disease Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Infectious Respiratory Disease Diagnostics Market Industry

4.2 Key Market Trends in Infectious Respiratory Disease Diagnostics Market Industry

4.3 Potential Opportunities in Infectious Respiratory Disease Diagnostics Market Industry

4.4 Key Challenges in Infectious Respiratory Disease Diagnostics Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Infectious Respiratory Disease Diagnostics Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Infectious Respiratory Disease Diagnostics Market Outlook By Segments

7.1 Infectious Respiratory Disease Diagnostics Market Outlook by Segments

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

8 North America Infectious Respiratory Disease Diagnostics Market Analysis And Outlook To 2030

8.1 Introduction to North America Infectious Respiratory Disease Diagnostics Markets in 2024

8.2 North America Infectious Respiratory Disease Diagnostics Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Infectious Respiratory Disease Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

9 Europe Infectious Respiratory Disease Diagnostics Market Analysis And Outlook To 2030

9.1 Introduction to Europe Infectious Respiratory Disease Diagnostics Markets in 2024

9.2 Europe Infectious Respiratory Disease Diagnostics Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Infectious Respiratory Disease Diagnostics Market Size Outlook By Segments, 2021-2030

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

10 Asia Pacific Infectious Respiratory Disease Diagnostics Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Infectious Respiratory Disease Diagnostics Markets in 2024

10.2 Asia Pacific Infectious Respiratory Disease Diagnostics Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Infectious Respiratory Disease Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

11 South America Infectious Respiratory Disease Diagnostics Market Analysis And Outlook To 2030

11.1 Introduction to South America Infectious Respiratory Disease Diagnostics Markets in 2024

11.2 South America Infectious Respiratory Disease Diagnostics Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Infectious Respiratory Disease Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

12 Middle East And Africa Infectious Respiratory Disease Diagnostics Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Infectious Respiratory Disease Diagnostics Markets in 2024

12.2 Middle East and Africa Infectious Respiratory Disease Diagnostics Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Infectious Respiratory Disease Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories Inc

Danaher

F. Hoffmann-La Roche Ltd

Koninklijke Philips N.V.

Qiagen

Quidel Corp

Siemens Healthcare GmbH

Thermo Fisher Scientific Inc

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Infectious Respiratory Disease Diagnostics Market Segmentation

By Product

Instruments

-Imaging Tests

-Respiratory Measurement Devices

-Others

Consumables

Services

 

By Sample Type

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

 

By Application

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Others

 

By Technology

Immunoassay

Molecular Diagnostics

Microbiology

Others

 

By End-User

Hospitals

Diagnostic Laboratories

Physician Offices

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)